Skip to main content

1 Result(s)

within Vojislav Ciric Remove this filter

and

  1. Article

    Open Access

    Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study

    Insulin glargine 300 U/mL (Gla-300) is a novel glargine formulation which shows slower and more prolonged absorption following subcutaneous administration in comparison to insulin glargine 100 U/mL. In this pr...

    Milena Velojic-Golubovic, Vojislav Ciric, Marija Dimitrijevic… in Diabetes Therapy (2021)

    Download PDF (522 KB) View Article